Gilbert, AZ, United States of America

Jim Abraham


 

Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Gilbert, AZ (US) (2022)
  • Southlake, TX (US) (2023)

Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jim Abraham: Innovating in Precision Medicine

Introduction

Jim Abraham, an accomplished inventor based in Gilbert, AZ, has made significant contributions to the field of precision medicine. With three patents to his name, he focuses on leveraging comprehensive molecular profiling to advance cancer treatment. His work demonstrates a commitment to improving patient outcomes through innovative approaches.

Latest Patents

Jim Abraham's latest inventions include two noteworthy patents that enhance treatment protocols for cancer patients. The first patent, "Classifying an entity for FOLFOX treatment," outlines a method for utilizing molecular profiling data to identify biomarker signatures. These signatures predict patient responses to FOLFOX treatment, which comprises the administration of 5-fluorouracil/leucovorin combined with oxaliplatin or irinotecan. This innovative approach allows for the selection of treatments tailored to individual molecular profiles.

The second patent, "Pan-cancer platinum response predictor," aims to similarly analyze biomarker signatures to evaluate patient responses to platinum-based chemotherapy. By developing machine learning models and data processing techniques, this patent provides a means to predict the effectiveness of treatments for various cancers, further advancing the field of precision medicine.

Career Highlights

Jim Abraham currently works at Caris MPI, Inc., where he contributes to groundbreaking research in precision oncology. His expertise in molecular profiling and treatment selection has positioned him as a key player within the company, driving innovation and enhancing the understanding of cancer therapies.

Collaborations

Throughout his career, Jim has collaborated with notable colleagues, including David Spetzler and Wolfgang Michael Korn. These partnerships reflect his commitment to interdisciplinary research and the pursuit of novel solutions in the medical field.

Conclusion

Jim Abraham's innovative spirit and dedication to precision medicine have led to the development of patents that hold the potential to transform cancer treatment. As he continues to work alongside leading professionals in the industry, his contributions will undoubtedly help shape the future of personalized healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…